179 related articles for article (PubMed ID: 29108270)
1. S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.
Tomasi ML; Cossu C; Spissu Y; Floris A; Ryoo M; Iglesias-Ara A; Wang Q; Pandol SJ; Bhowmick NA; Seki E; Posadas EM; Lu SC
Oncotarget; 2017 Oct; 8(45):78851-78869. PubMed ID: 29108270
[TBL] [Abstract][Full Text] [Related]
2. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells.
Chen H; Xia M; Lin M; Yang H; Kuhlenkamp J; Li T; Sodir NM; Chen YH; Josef-Lenz H; Laird PW; Clarke S; Mato JM; Lu SC
Gastroenterology; 2007 Jul; 133(1):207-18. PubMed ID: 17631143
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting
Simile MM; Peitta G; Tomasi ML; Brozzetti S; Feo CF; Porcu A; Cigliano A; Calvisi DF; Feo F; Pascale RM
Oncotarget; 2019 Apr; 10(29):2835-2854. PubMed ID: 31073374
[TBL] [Abstract][Full Text] [Related]
4. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
Maldonado LY; Arsene D; Mato JM; Lu SC
Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.
Lo TF; Tsai WC; Chen ST
PLoS One; 2013; 8(9):e75628. PubMed ID: 24098708
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
7. Fluorinated N,N-dialkylaminostilbenes repress colon cancer by targeting methionine S-adenosyltransferase 2A.
Zhang W; Sviripa V; Chen X; Shi J; Yu T; Hamza A; Ward ND; Kril LM; Vander Kooi CW; Zhan CG; Evers BM; Watt DS; Liu C
ACS Chem Biol; 2013 Apr; 8(4):796-803. PubMed ID: 23363077
[TBL] [Abstract][Full Text] [Related]
8. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics.
Nordgren KK; Peng Y; Pelleymounter LL; Moon I; Abo R; Feng Q; Eckloff B; Yee VC; Wieben E; Weinshilboum RM
Drug Metab Dispos; 2011 Nov; 39(11):2135-47. PubMed ID: 21813468
[TBL] [Abstract][Full Text] [Related]
9. MAT2A/2B promote porcine intramuscular preadipocyte proliferation through ERK signaling pathway.
Zhao C; Wu H; Chen P; Yi B; Ma Y; Deng K
Anim Sci J; 2019 Sep; 90(9):1278-1286. PubMed ID: 31293025
[TBL] [Abstract][Full Text] [Related]
10. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.
Quinlan CL; Kaiser SE; Bolaños B; Nowlin D; Grantner R; Karlicek-Bryant S; Feng JL; Jenkinson S; Freeman-Cook K; Dann SG; Wang X; Wells PA; Fantin VR; Stewart AE; Grant SK
Nat Chem Biol; 2017 Jul; 13(7):785-792. PubMed ID: 28553945
[TBL] [Abstract][Full Text] [Related]
11. Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta.
Ramani K; Yang H; Xia M; Ara AI; Mato JM; Lu SC
Hepatology; 2008 Feb; 47(2):521-31. PubMed ID: 18041713
[TBL] [Abstract][Full Text] [Related]
12. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
[TBL] [Abstract][Full Text] [Related]
13. Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation.
Ramani K; Yang H; Kuhlenkamp J; Tomasi L; Tsukamoto H; Mato JM; Lu SC
Hepatology; 2010 Mar; 51(3):986-95. PubMed ID: 20043323
[TBL] [Abstract][Full Text] [Related]
14. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine.
Martínez-Chantar ML; Latasa MU; Varela-Rey M; Lu SC; García-Trevijano ER; Mato JM; Avila MA
J Biol Chem; 2003 May; 278(22):19885-90. PubMed ID: 12660248
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Tumour Biol; 2016 Oct; 37(10):13155-13166. PubMed ID: 27456356
[TBL] [Abstract][Full Text] [Related]
16. Human Mat2A Uses an Ordered Kinetic Mechanism and Is Stabilized but Not Regulated by Mat2B.
Bailey J; Douglas H; Masino L; de Carvalho LPS; Argyrou A
Biochemistry; 2021 Nov; 60(47):3621-3632. PubMed ID: 34780697
[TBL] [Abstract][Full Text] [Related]
17. The Transition-State Structure for Human MAT2A from Isotope Effects.
Firestone RS; Schramm VL
J Am Chem Soc; 2017 Oct; 139(39):13754-13760. PubMed ID: 28880543
[TBL] [Abstract][Full Text] [Related]
18. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
Lu G; Sun Y; An S; Xin S; Ren X; Zhang D; Wu P; Liao W; Ding Y; Liang L
Exp Mol Pathol; 2015 Aug; 99(1):173-9. PubMed ID: 26103003
[TBL] [Abstract][Full Text] [Related]
20. MAT2B expression correlates with poor prognosis in triple-negative breast cancer.
Xu J; Wu D; Wang S; Wang Z
Cancer Manag Res; 2019; 11():5501-5511. PubMed ID: 31354356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
